Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biosimilar”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04843943
What this trial is testing

Sintilimab Combined With Bevacizumab Biosimilar for Potentially Resectable Intermediate HCC

Who this might be right for
Hepatocellular Carcinoma
Fudan University 30
Large-scale testing (Phase 3)Study completedNCT04607629
What this trial is testing

An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma

Who this might be right for
Bronchial Asthma
AO GENERIUM 192
Large-scale testing (Phase 3)Study completedNCT05802862
What this trial is testing

Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in China

Who this might be right for
Diabetes
Sunshine Lake Pharma Co., Ltd. 414
Not applicableUnknownNCT05009017
What this trial is testing

Multi-Centre, Observational Study on Safety of Bevacizumab Biosimilars in Clinical Practice Among Chinese Patients

Who this might be right for
Biosimilar
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 272
Testing effectiveness (Phase 2)Looking for participantsNCT07560488
What this trial is testing

Ipilimumab N01 Combined With Sintilimab, Bevacizumab Biosimilar, and Hepatic Arterial Infusion Chemotherapy as Conversion Therapy for Unresectable Intermediate-Advanced Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular CarcinomaConversion Therapy
Tianjin Medical University Cancer Institute and Hospital 43
Large-scale testing (Phase 3)Not Yet RecruitingNCT07162883
What this trial is testing

Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Qilu Pharmaceutical Co., Ltd. 122
Early research (Phase 1)Study completedNCT04439929
What this trial is testing

Comparative Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of Adalimumab in Healthy Subjects

Who this might be right for
Healthy Participants
Turgut İlaçları A.Ş. 168
Large-scale testing (Phase 3)Study completedNCT05539872
What this trial is testing

Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy Volunteers

Who this might be right for
PharmacokineticsPharmacodynamics
Amphastar Pharmaceuticals, Inc. 69
Early research (Phase 1)Study completedNCT06738277
What this trial is testing

This is Comparative Study in Normal Healthy Subjects to Evaluate Pharmacokinetics, Safety, Tolerability of Bmab 1200 -Autoinjector (AI) After Single Subcutaneous Injection (45 mg) in Comparison With Bmab 1200 -Prefilled Syringe (PFS).

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Biocon Biologics UK Ltd 186
Not applicableStudy completedNCT05796245
What this trial is testing

Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis

Who this might be right for
Arthritis, RheumatoidColitis, UlcerativeCrohn Disease+1 more
Pfizer 2,207
Large-scale testing (Phase 3)Not Yet RecruitingNCT06847334
What this trial is testing

Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX17 Vs. Keytruda® in the First-Line Treatment of Advanced Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Shanghai Henlius Biotech 772
Testing effectiveness (Phase 2)Looking for participantsNCT07324824
What this trial is testing

Sintilimab Plus Bevacizumab Biosimilar as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaNeoadjuvant TherapySintilimab+1 more
Sun Yat-sen University 37
Large-scale testing (Phase 3)Study completedNCT06159790
What this trial is testing

Compare Efficacy, Safety, and Immunogenicity of GME751 and EU-authorized Keytruda in Adult Participants With Untreated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Metastatic NSCLC
Sandoz 218
Testing effectiveness (Phase 2)UnknownNCT04796025
What this trial is testing

TACE Combined With Sintilimab Plus Bevacizumab Biosimilar in Hepatocellular Carcinoma (BCLC-C Stage ): a Prospective Single-arm Phase II Clinical Study

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 34
Not applicableStudy completedNCT04854707
What this trial is testing

An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data

Who this might be right for
Reproductive IssuesReproductive DisorderFertility Disorders+3 more
IVFarma LLC 5,484
Not applicableStudy completedNCT01459653
What this trial is testing

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Who this might be right for
Febrile NeutropeniaCancerBreast Cancer+6 more
Sandoz 1,496
Not applicableLooking for participantsNCT07425639
What this trial is testing

ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar

Who this might be right for
Chronic Spontaneous Urticaria (CSU)Allergic Asthma
Celltrion HealthCare France 225
Large-scale testing (Phase 3)Study completedNCT04450329
What this trial is testing

Compare SB15 (Proposed Aflibercept Biosimilar) to Eylea in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Samsung Bioepis Co., Ltd. 449
Testing effectiveness (Phase 2)Study completedNCT06083662
What this trial is testing

Neratinib and Trastuzumab Biosimilar in Patients with HER2 Mutated Advanced Solid Cancers

Who this might be right for
Metastatic CancerHER2 Gene Mutation
Korea University Guro Hospital 42
Early research (Phase 1)Study completedNCT04014062
What this trial is testing

Comparative, Pharmacokinetic and Pharmacodynamic Study of Subcutaneous Injections of INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.

Who this might be right for
Pharmacokinetic Bioequivalence Study in Human Healthy Volunteers
Intas Pharmaceuticals, Ltd. 144
Next Page